TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EMvision Medical Devices Ltd. ( (AU:EMV) ) has shared an update.
EMvision Medical Devices Ltd announced a change in the director’s interest, with Carmel Monaghan acquiring 200,000 unlisted options at an exercise price of $3.00, set to expire on December 31, 2028. This change, approved at the company’s AGM, reflects a strategic move to align the interests of the director with the company’s growth objectives, potentially impacting stakeholder confidence and market perception positively.
The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMvision Medical Devices Ltd operates in the medical devices industry, focusing on developing innovative imaging technologies for healthcare applications.
Average Trading Volume: 86,792
Technical Sentiment Signal: Buy
Current Market Cap: A$173.8M
For detailed information about EMV stock, go to TipRanks’ Stock Analysis page.